AMMI Canada – CACMID
Annual Conference

APRIL 29 – MAY 2, 2025

Program

About the Conference

The AMMI Canada – CACMID Annual Conference offers an interactive platform for leading experts in diagnostic microbiology, antimicrobial stewardship, infectious diseases, infection prevention and control, and public health to convene. Celebrating the 20th anniversary of the conjoint meeting between AMMI Canada and CACMID, this conference draws participants from across Canada and internationally. Continuing the tradition, the 2025 conference will deliver updates on a broad range of topics to a diverse group of professionals, including clinicians, microbiologists, laboratory technologists, public health experts, infection prevention and control practitioners, epidemiologists, pharmacists, students and residents.

In addition to the pre-conference Trainees’ Day, the program will feature plenary sessions, cutting-edge clinical lectures, accredited co-developed learning activities, short oral presentations, rapid-fire presentations, poster presentations, a case report symposium, and an exhibit hall. New this year are “Lightning Learning” sessions—concise, focused learning opportunities on specific topics. 

The conference provides an invaluable opportunity for attendees to showcase their research and stay abreast of the latest developments in microbiology, infection control, and infectious diseases in both adults and children. Beyond the scientific program, the event also fosters networking, idea exchange, and reconnection among colleagues.

Conference Learning Objectives

After attending the AMMI Canada – CACMID Annual Conference, participants will be able to:

  • Summarize the latest updates in the fields of diagnostic microbiology, antimicrobial stewardship, infectious diseases, infection prevention and control, and public health.

  • Create support systems and engage with a network of experts in the fields of diagnostic microbiology.

Scientific Planning Committee (SPC)

Co-Chairs

Rob Kozak
Susan Poutanen

Committee Members

Samuel Bourassa-Blanchette
Danielle Brabant-Kirwan
Marthe Charles
William Connors
Cora Constantinescu
Ramzi Fattouh
Jessica Forbes
Catherine Hogan
Agatha Jassem
Ruwandi Kariyawasam
Farhan Khan
Adam Komorowski
Philippe Lagacé-Wiens
Vanessa Meier-Stephenson
Ninad Mehta
Esther Nagai
David Patrick
Glenn Patriquin
Shaqil Peermohamed
Peter Pieroni
Melissa Richard-Greenblatt
Earl Rubin
Prameet M. Sheth
Robert Taylor
Vanessa Tran
Jason Zou

Accreditation and CanMEDS

The AMMI Canada Continuing Professional Development committee chair, Dr. Glenn Patriquin, is responsible for ensuring that the AMMI Canada – CACMID Annual Conference is compliant with the Royal College of Physicians and Surgeons national standard of support of accredited CPD activities.

For specialists certified with the Royal College of physicians and surgeons of Canada: the AMMI Canada – CACMID annual conference is an accredited group learning activity (Section 1) as defined by the maintenance of certification program of the Royal College of physicians and surgeons of Canada and approved by AMMI Canada. You may claim a maximum of 24.5 CME credits. Please use the following link to claim your CME hours. If you require a hard copy form, please visit the registration desk.

  1. “My MOC” Platform (formerly MAINPORT)
    In prior years, Group Learning Activities such as conferences were transferred directly into participants’ MAINPORT ePortfolio. With the launch of the new “My MOC” platform in August 2024, participants are asked to submit their conference activity hours manually into their “My MOC”, which can be accessed through “My Portal” on the Royal College website.
  2. For specialists certified with the American Medical Association (AMA): through an arrangement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association physicians may convert Royal College MOC credits to AMA PRA Category 1 credits. Information on the process to converting Royal College MOC credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.
  3. For fellows and specialists of the Canadian College of Microbiologists and diplomats of the American Board of Medical Microbiology the Canadian College of Microbiologist: The Canadian College of Microbiologists (CCM) accredits the AMMI Canada – CACMID Annual Conference for CE credits. Certificates of continuing education activity are available through the CCM for documentation of attendance and maintenance of certification. A one-hour educational activity is equivalent to one CE credit. Program evaluation forms and record of CE activity can be obtained, in returned once completed by e-mail to the FCCM co-chair Heather Adam (hadam@shared-healthmb.ca) following the conference.

Certificates of Attendance

Certificates of Attendance will be sent to all registered delegates who completed the CME form. If you have not received your certificate by end of day on May 23rd, 2025 please reach out to meetings@ammi.ca.

CanMEDS

CanMEDS is the framework that identifies and describes the abilities physicians require to effectively meet the health care needs of the people they serve. These abilities are grouped thematically under seven rules. A competent physician seamlessly integrates the competencies of all seven CanMEDS roles. CanMEDS roles have been identified for each session taking place during the annual conference.

Medical Expert
Scholar
Professional
Collaborator
Communicator
Leader
Health Advocate

(2022). Royal College of Physicians and Surgeons of Canada. CanMEDS Framework

Conflict of Interest Disclosures

Name
Role(s)
Disclosure
Layla Al-Yasiri
Abstract Presenter
No Conflict
Reema Alabdulqader
Abstract Presenter
No Conflict
Robert E. Ariano
Speaker/Faculty
No Conflict
Stephanie Booth
Speaker/Faculty
No Conflict
Samuel Bourassa-Blanchette
Scientific Planning Committee Member
Payment: Pfizer (gave talk on pneumococcal vaccination)
DANIELLE BRABANT-KIRWAN
Central Planning Committee Member, Scientific Planning Committee Member, Abstract Reviewer
No Conflict
Vivne Brown
Co-Developed Speaker/Faculty
Payment: Astellas, Bayer, Biosyent, GSK, Merck, Moderna, Pfizer, Sanofi, Seqirus (Presentatino of CME); Ad Board: Merck, Pfizer, Astellas, GSK; Board Member: Immunize Canada
Yen-Giang Bui
Speaker/Faculty
No Conflict
Guillaume Butler-Laporte
Speaker/Faculty
No Conflict
Dana Cabiles
Speaker/Faculty
No Conflict
Julie Carson
Speaker/Faculty
No Conflict
Adrian Chung Hin Chan
Abstract Presenter
No Conflict
Carmen L. Charlton
Speaker/Faculty, Co-Developed Speaker/Faculty
Grant/Clinical Trial: Merck, Roche (funded grants and validation kits)
Shawn Clark
Speaker/Faculty
No Conflict
Carla Coffin
Speaker/Faculty
Ad Board and Grant: Gilead Sciences (Paid to the University of Calgary); Patent: Quadrumix Biotechnology (Co-Director)
Jeannette Comeau
Co-Developed Speaker/Faculty
Funded Clinical Trials: Pfizer, GlaxoSmithKline inc, ModernaTX, Merck Canada, CanSino Biologics inc. & Barinthus Biotherapeutics, Sanofi Pasteur Inc., Entos pharmaceuticals inc, VBI Vaccines, VIDO-interVac; Grants Funded: Canadian Institutes of Health Research (CIHR), Canadian Immunization Network (CIRN)
William Connors
Central Planning Committee Member, Scientific Planning Committee Member, Abstract Reviewer, Moderator
No Conflict
Cora Constantinescu
Speaker/Faculty
Payment: Canadian research Network, Canadian Federation for Women in Medicine (honoraria for talks); Ad Board: AVIR Pharma, CSL Seqirus; Grants/Clinical Trials: CIRN, PHAC, CIHR
Angel Desai
Speaker/Faculty
No Conflict
Marc Desjardins
Speaker/Faculty
No Conflict
Wayne Ghesquiere
Speaker/Faculty
No Conflict
Clayton W. Hall
Abstract Presenter
No Conflict
Scott A Halperin
Speaker/Faculty
Ad Board: GlaxoSmithKline, Sanofi Pasteur (I have served on ad hoc advisory boards for GlaxoSmithKline and Sanofi Pasteur, manufacturers of pertussis vaccines)
Jennifer Happe
Abstract Presenter
Ad Board: Public Health Agency of Canada, National Advisory Committee on Infection Prevention and Control (PHAC NAC-IPC) (SME)
Suefay Harumi
Abstract Presenter
No Conflict
Catherine Hogan
Speaker/Faculty, Scientific Planning Committee Member
Payment: Inflammatix (consultancy); Grant/Clinical Trial: Health Research BC, UBC CDC
Mitchell Jeffs
Speaker/Faculty
No Conflict
Tomy Joseph
Speaker/Faculty
No Conflict
Dina Kao
Co-Developed Speaker/Faculty
Payment: Vedanta (consulting); Ad Board: Ferring; Grant/Clinical Trial: Vedanta
Farhan Khan
Scientific Planning Committee Member, Working Group Member, Abstract Reviewer
No Conflict
Adam S. Komorowski
Speaker/Faculty, Scientific Planning Committee Member, Abstract Reviewer
Payment: Ontario Ministry of Health; Infectious Diseases Society of America; Pandemic EVIDENCE Collaboration, University of Oxford; European Society of Clinical Microbiology and Infectious Diseases (Salary grant (OMOH), honorarium (IDSA), travel funding (University of Oxford, ESCMID)); Grant/Clinical Trial: Canadian Institutes of Health Research (co-Investigator)
Philippe Lagacé-Wiens
Speaker/Faculty, Scientific Planning Committee Member, Working Group Member, Moderator
No Conflict
Philip Lam
Speaker/Faculty
No Conflict
Lawrence Lau
Speaker/Faculty
No Conflict
Benjamin Leis
Speaker/Faculty
No Conflict
Anthony Lieu
Speaker/Faculty
No Conflict
Calvin Ka-Fung Lo
Abstract Presenter
No Conflict
Carson Lo
Abstract Presenter
No Conflict
Yves Longtin
Speaker/Faculty, Central Planning Committee Member
No Conflict
thomas louie
Co-Developed Speaker/Faculty
Payment: Ferring (advisory role); Ad Board: Merck (Discussing Fidaxomicin); Grant/Clinical Trial: Vedanta, Rebiotix/Ferring, Crestone, Adiso (Investigator in clinical trials)
Christopher Lowe
Central Planning Committee Member, Co-Treasurer
No Conflict
Tarah Lynch
Speaker/Faculty
No Conflict
Jessica Mannette
Speaker/Faculty
No Conflict
Natalie Marshall
Speaker/Faculty
No Conflict
Allison McGeer
Co-Developed Speaker/Faculty
Payment: CCRN, Primed (Funding for webinar presentations); Ad Board: AstraZeneca, Cidara, GSK, Leyden Laboratories Merck, Pfizer, Sanofi (membership on advisory boards, outcome adjudication committees, DSMB); Grant/Clinical Trial: Pfizer, Merck (Investigator-initiated grant funding to my institution)
Ninad Mehta
Scientific Planning Committee Member, Working Group Member, Moderator
No Conflict
Vanessa Meier-Stephenson
Speaker/Faculty
No Conflict
Matthew S. Miller
Speaker/Faculty, Co-Developed Speaker/Faculty
Payment: Roche, GSK, Seqirus, Sanofi, Aramis Biotechnologies, Grifols (Scientific Advisory Board Honoraria and Speaker Fees); Ad Board: StokedBio, Kapoose Creek Bio (Scientific Advisory Board); Grant/Clinical Trial: Providence Therapeutics, Zentek, JN Nova, Lactiga (Grants related to infectious disease medical countermeasure testing and development); Patent: McMaster University (Patents related to use of aptamers for diagnostic and therapeutic applications); Investment: AeroImmune Inc (Co-founder and CSO)
Jeya Nadarajah
Speaker/Faculty
No Conflict
Ashley Osa-Peters
Abstract Presenter
No Conflict
Jesse Papenburg
Co-Developed Speaker/Faculty
Ad Board: Enanta (Ad hoc ad board); Grant/Clinical Trial: Merck (Sit investigator for RCT on Clesrovimab); Other: NACI and CIQ (Member of NACI and CIQ RSV working groups)
Leighanne Olivia Parkes
Speaker/Faculty
No Conflict
David Patrick
Scientific Planning Committee Member
No Conflict
Glenn Patriquin
Scientific Planning Committee Member, Abstract Reviewer
Grant/Clinical Trial: Research Nova Scotia (Grant holder for Nova Scotia zoonotic serosurvey)
Charlotte Penner
Speaker/Faculty
No Conflict
Jeffrey Pernica
Speaker/Faculty
Grant/Clinical Trial: MedImmune, Merck, DiaSorin (MedImmune and Merck have provided grant funds to my institution for research purposes. DiaSorin has provided in-kind support (test kits) to my institution for research purposes)
Peter Pieroni
Scientific Planning Committee Member, Working Group Member, Abstract Reviewer, Abstract Presenter
No Conflict
Rupeena Purewal
Speaker/Faculty
Payment: University of Saskatchewan CME program (speaker honoraria); Grant/Clinical Trial: Principle investigator for PIPE study (CIHR funding), PI for COVID studies (SHRF and OVDR), Co-investigator for POPCORN Study (CIHR funding)
Melissa Richard-Greenblatt
Scientific Planning Committee Member
No Conflict
Wallis Rudnick
Abstract Presenter
No Conflict
Cole Schonhofer
Abstract Presenter
No Conflict
Sheri Scott
Speaker/Faculty
No Conflict
Jonathan Stokes
Speaker/Faculty
No Conflict
Kathryn Suh
Speaker/Faculty
No Conflict
Robert Taylor
Scientific Planning Committee Member, Working Group Member
No Conflict
Vanessa Tran
Scientific Planning Committee Member
No Conflict
Cailey Turner
Abstract Presenter
No Conflict
Nicholas A. Turner
Speaker/Faculty, Co-Developed Speaker/Faculty
Payment: Putnam & Associates, Techspert (Double blind consultation for pharmaceutical company); Grant/Clinical Trial: NIH, Basilea, CDC (Investigator on NIH funded dalbavancin trial; adjudicator on Basilea funded ceftrobiprole trial; subinvestigator on CDC Epicenters study)
Kartikay Tyagi
Abstract Presenter
No Conflict
Mario Valdes
Abstract Presenter
No Conflict
Stephen Vaughan
Speaker/Faculty
Payment: Pfizer, VIIV, GSK (Presentations on Vaccines (RSV, PCV-20), Anti-retrovirals); Ad Board: Bavarian Nordic (Moderator for Consutlancy meeting on Chik Vaccine)
Bing Wang
Abstract Reviewer
No Conflict
Kathleen Whyte
Speaker/Faculty, Abstract Presenter
No Conflict
Christopher Wituik
Speaker/Faculty
No Conflict
Joseph Zeppa
Speaker/Faculty
No Conflict
Jason Zou
Scientific Planning Committee Member, Abstract Presenter, Moderator
No Conflict
Jordan
Abstract Presenter
No Conflict

Conflict of Interest Disclosures

Name
Role(s)
Disclosure
Layla Al-Yasiri
Abstract Presenter
No Conflict
Reema Alabdulqader
Abstract Presenter
No Conflict
Robert E. Ariano
Speaker/Faculty
No Conflict
Stephanie Booth
Speaker/Faculty
No Conflict
Samuel Bourassa-Blanchette
Scientific Planning Committee Member
Payment: Pfizer (gave talk on pneumococcal vaccination)
DANIELLE BRABANT-KIRWAN
Central Planning Committee Member, Scientific Planning Committee Member, Abstract Reviewer
No Conflict
Vivne Brown
Co-Developed Speaker/Faculty
Payment: Astellas, Bayer, Biosyent, GSK, Merck, Moderna, Pfizer, Sanofi, Seqirus (Presentatino of CME); Ad Board: Merck, Pfizer, Astellas, GSK; Board Member: Immunize Canada
Yen-Giang Bui
Speaker/Faculty
No Conflict
Guillaume Butler-Laporte
Speaker/Faculty
No Conflict
Dana Cabiles
Speaker/Faculty
No Conflict
Julie Carson
Speaker/Faculty
No Conflict
Adrian Chung Hin Chan
Abstract Presenter
No Conflict
Carmen L. Charlton
Speaker/Faculty, Co-Developed Speaker/Faculty
Grant/Clinical Trial: Merck, Roche (funded grants and validation kits)
Shawn Clark
Speaker/Faculty
No Conflict
Carla Coffin
Speaker/Faculty
Ad Board and Grant: Gilead Sciences (Paid to the University of Calgary); Patent: Quadrumix Biotechnology (Co-Director)
Jeannette Comeau
Co-Developed Speaker/Faculty
Funded Clinical Trials: Pfizer, GlaxoSmithKline inc, ModernaTX, Merck Canada, CanSino Biologics inc. & Barinthus Biotherapeutics, Sanofi Pasteur Inc., Entos pharmaceuticals inc, VBI Vaccines, VIDO-interVac; Grants Funded: Canadian Institutes of Health Research (CIHR), Canadian Immunization Network (CIRN)
William Connors
Central Planning Committee Member, Scientific Planning Committee Member, Abstract Reviewer, Moderator
No Conflict
Cora Constantinescu
Speaker/Faculty
Payment: Canadian research Network, Canadian Federation for Women in Medicine (honoraria for talks); Ad Board: AVIR Pharma, CSL Seqirus; Grants/Clinical Trials: CIRN, PHAC, CIHR
Angel Desai
Speaker/Faculty
No Conflict
Marc Desjardins
Speaker/Faculty
No Conflict
Wayne Ghesquiere
Speaker/Faculty
No Conflict
Clayton W. Hall
Abstract Presenter
No Conflict
Scott A Halperin
Speaker/Faculty
Ad Board: GlaxoSmithKline, Sanofi Pasteur (I have served on ad hoc advisory boards for GlaxoSmithKline and Sanofi Pasteur, manufacturers of pertussis vaccines)
Jennifer Happe
Abstract Presenter
Ad Board: Public Health Agency of Canada, National Advisory Committee on Infection Prevention and Control (PHAC NAC-IPC) (SME)
Suefay Harumi
Abstract Presenter
No Conflict
Catherine Hogan
Speaker/Faculty, Scientific Planning Committee Member
Payment: Inflammatix (consultancy); Grant/Clinical Trial: Health Research BC, UBC CDC
Mitchell Jeffs
Speaker/Faculty
No Conflict
Tomy Joseph
Speaker/Faculty
No Conflict
Dina Kao
Co-Developed Speaker/Faculty
Payment: Vedanta (consulting); Ad Board: Ferring; Grant/Clinical Trial: Vedanta
Farhan Khan
Scientific Planning Committee Member, Working Group Member, Abstract Reviewer
No Conflict
Adam S. Komorowski
Speaker/Faculty, Scientific Planning Committee Member, Abstract Reviewer
Payment: Ontario Ministry of Health; Infectious Diseases Society of America; Pandemic EVIDENCE Collaboration, University of Oxford; European Society of Clinical Microbiology and Infectious Diseases (Salary grant (OMOH), honorarium (IDSA), travel funding (University of Oxford, ESCMID)); Grant/Clinical Trial: Canadian Institutes of Health Research (co-Investigator)
Philippe Lagacé-Wiens
Speaker/Faculty, Scientific Planning Committee Member, Working Group Member, Moderator
No Conflict
Philip Lam
Speaker/Faculty
No Conflict
Lawrence Lau
Speaker/Faculty
No Conflict
Benjamin Leis
Speaker/Faculty
No Conflict
Anthony Lieu
Speaker/Faculty
No Conflict
Calvin Ka-Fung Lo
Abstract Presenter
No Conflict
Carson Lo
Abstract Presenter
No Conflict
Yves Longtin
Speaker/Faculty, Central Planning Committee Member
No Conflict
thomas louie
Co-Developed Speaker/Faculty
Payment: Ferring (advisory role); Ad Board: Merck (Discussing Fidaxomicin); Grant/Clinical Trial: Vedanta, Rebiotix/Ferring, Crestone, Adiso (Investigator in clinical trials)
Christopher Lowe
Central Planning Committee Member, Co-Treasurer
No Conflict
Tarah Lynch
Speaker/Faculty
No Conflict
Jessica Mannette
Speaker/Faculty
No Conflict
Natalie Marshall
Speaker/Faculty
No Conflict
Allison McGeer
Co-Developed Speaker/Faculty
Payment: CCRN, Primed (Funding for webinar presentations); Ad Board: AstraZeneca, Cidara, GSK, Leyden Laboratories Merck, Pfizer, Sanofi (membership on advisory boards, outcome adjudication committees, DSMB); Grant/Clinical Trial: Pfizer, Merck (Investigator-initiated grant funding to my institution)
Ninad Mehta
Scientific Planning Committee Member, Working Group Member, Moderator
No Conflict
Vanessa Meier-Stephenson
Speaker/Faculty
No Conflict
Matthew S. Miller
Speaker/Faculty, Co-Developed Speaker/Faculty
Payment: Roche, GSK, Seqirus, Sanofi, Aramis Biotechnologies, Grifols (Scientific Advisory Board Honoraria and Speaker Fees); Ad Board: StokedBio, Kapoose Creek Bio (Scientific Advisory Board); Grant/Clinical Trial: Providence Therapeutics, Zentek, JN Nova, Lactiga (Grants related to infectious disease medical countermeasure testing and development); Patent: McMaster University (Patents related to use of aptamers for diagnostic and therapeutic applications); Investment: AeroImmune Inc (Co-founder and CSO)
Jeya Nadarajah
Speaker/Faculty
No Conflict
Ashley Osa-Peters
Abstract Presenter
No Conflict
Jesse Papenburg
Co-Developed Speaker/Faculty
Ad Board: Enanta (Ad hoc ad board); Grant/Clinical Trial: Merck (Sit investigator for RCT on Clesrovimab); Other: NACI and CIQ (Member of NACI and CIQ RSV working groups)
Leighanne Olivia Parkes
Speaker/Faculty
No Conflict
David Patrick
Scientific Planning Committee Member
No Conflict
Glenn Patriquin
Scientific Planning Committee Member, Abstract Reviewer
Grant/Clinical Trial: Research Nova Scotia (Grant holder for Nova Scotia zoonotic serosurvey)
Charlotte Penner
Speaker/Faculty
No Conflict
Jeffrey Pernica
Speaker/Faculty
Grant/Clinical Trial: MedImmune, Merck, DiaSorin (MedImmune and Merck have provided grant funds to my institution for research purposes. DiaSorin has provided in-kind support (test kits) to my institution for research purposes)
Peter Pieroni
Scientific Planning Committee Member, Working Group Member, Abstract Reviewer, Abstract Presenter
No Conflict
Rupeena Purewal
Speaker/Faculty
Payment: University of Saskatchewan CME program (speaker honoraria); Grant/Clinical Trial: Principle investigator for PIPE study (CIHR funding), PI for COVID studies (SHRF and OVDR), Co-investigator for POPCORN Study (CIHR funding)
Melissa Richard-Greenblatt
Scientific Planning Committee Member
No Conflict
Wallis Rudnick
Abstract Presenter
No Conflict
Cole Schonhofer
Abstract Presenter
No Conflict
Sheri Scott
Speaker/Faculty
No Conflict
Jonathan Stokes
Speaker/Faculty
No Conflict
Kathryn Suh
Speaker/Faculty
No Conflict
Robert Taylor
Scientific Planning Committee Member, Working Group Member
No Conflict
Vanessa Tran
Scientific Planning Committee Member
No Conflict
Cailey Turner
Abstract Presenter
No Conflict
Nicholas A. Turner
Speaker/Faculty, Co-Developed Speaker/Faculty
Payment: Putnam & Associates, Techspert (Double blind consultation for pharmaceutical company); Grant/Clinical Trial: NIH, Basilea, CDC (Investigator on NIH funded dalbavancin trial; adjudicator on Basilea funded ceftrobiprole trial; subinvestigator on CDC Epicenters study)
Kartikay Tyagi
Abstract Presenter
No Conflict
Mario Valdes
Abstract Presenter
No Conflict
Stephen Vaughan
Speaker/Faculty
Payment: Pfizer, VIIV, GSK (Presentations on Vaccines (RSV, PCV-20), Anti-retrovirals); Ad Board: Bavarian Nordic (Moderator for Consutlancy meeting on Chik Vaccine)
Bing Wang
Abstract Reviewer
No Conflict
Kathleen Whyte
Speaker/Faculty, Abstract Presenter
No Conflict
Christopher Wituik
Speaker/Faculty
No Conflict
Joseph Zeppa
Speaker/Faculty
No Conflict
Jason Zou
Scientific Planning Committee Member, Abstract Presenter, Moderator
No Conflict
Jordan
Abstract Presenter
No Conflict